Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Trop Med Int Health. 2022 Oct 31;27(11):990–998. doi: 10.1111/tmi.13823

Table 2.

Adverse birth outcomes among infants born to women in Botswana, by CP exposure.

Adverse Birth Outcomes CP (n=5,883) No CP (n=17,150) Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)
Preterm Delivery 998 (16.96) 3,031 (17.62) 0.96 (0.88 – 1.03) 0.95 (0.87 – 1.03)
Very Preterm Delivery * 345 (5.86) 1,167 (6.80) 0.85 (0.75 – 0.97) 0.85 (0.75 – 0.97)
Neonetal Death * 59 (1.03) 260 (1.55) 0.65 (0.50 – 0.87) 0.66 (0.49 – 0.88)
Stillbirth 117 (1.99) 346 (2.02) 0.99 (0.79 – 1.21) 1.04 (0.84 – 1.29)
SGA 962 (16.35) 2754 (16.06) 1.02 (0.94 – 1.10) 1.03 (0.95 – 1.12)
Very SGA 410 (6.97) 1,097 (6.40) 1.10 (0.97 – 1.23) 1.08 (0.96 – 1.22)

The data are n (%), unadjusted odds ratio (95% CI) or adjusted odds ratio (95% CI). All models were adjusted for HIV status, maternal age, gravida, occupation, and educational attainment. CP = Chloroquine and Proguanil. Adverse birth outcomes among women from three (Nyangabwe, Ghanzi, Maun, Total, N=23,033) government hospitals in Botswana.

*

indicates a statistically significant reduction in adjusted odds ratio (p-value < 0.05). CI = Confidence Interval.